FindTrial
Sign In

A clinical trial to study the effects of one therapy,Virechana karma and one drug , vyoshadi saktu in patients with metabolic syndrome ( santarpana janaya vyadhi)

Comparative Clinical Evaluation Of Virechana Karma and Vyoshadi Saktu Pana in Metabolic Syndrome(Santarpana Janya Vyadhi) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074639
Enrollment
40
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

None listed

Sponsors

Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group 20 years to 50 years. 2.Patient fulfilling NCEP ATP III criteria. 3.Patient fit for Virechana procedure.

Exclusion criteria

Exclusion criteria: 1.Uncontrolled diabetes Mellitus (Type 2) with complications such as nephropathy. 2.Uncontrolled hypertension or with complications. 3.Known case of IHD, CHF and any other vascular disorders. 4.Patient suffering from ano-rectal ailments.

Design outcomes

Primary

MeasureTime frame
No improvement: 0-25% Mild improvement: 26-50% Moderate improvement: 51-75% Marked improvement: 76-99% Complete remission: 100%Timepoint: 1st day, 20th day—

Secondary

MeasureTime frame
Assessment of sign and symptomsTimepoint: after one month of completion of therapy—

Countries

India

Contacts

Public ContactDr Subhi Agarwal

Rishikul Campus Haridwar, Uttarakhand Ayurved University

kripayanam@yahoo.com9758264264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026